Seattle Genetics, Inc.

Seagen Inc.

Road Runner Holdco LLC

Michael Sun

Kenneth Gould

Eric Sievers

Dana Kennedy

Damon L Meyer

Stephen C Alley

Michael Torgov

Nathan Ihle

Michael Y Torgov

Damon Meyer

Stephen Charles Alley

Feng Huang

Joo C Chung

Disclosed are methods of purifying mixtures comprising benzoidiazepine antibody-drug conjugates.

Activated carbon filtration for purification of benzodiazepine ADCs

Methods for the treatment of CD30-expressing cancers are provided. The methods comprise administering to a subject in need thereof a weekly dose of from about 0.8 mg/kg to about 1.8 mg/kg of an antibody-drug conjugate compound having formula (I); or a pharmaceutically acceptable salt thereof; wherein: mAb is an anti-CD30 antibody unit, S is a sulfur atom of the antibody, A- is a Stretcher unit, and p is from about 3 to about 5. 

Weekly dosing regimens for anti-CD30 VC-PAB-MMAE antibody drug-conjugates

A protein containing one or more activatable groups, e.g., an antibody, is subjected to partial or complete reduction of one or more such bonds to form reactive groups; the resulting protein is reacted with a drug which is reactive with some of the reactive groups, such as certain radiometals, chelating agents, and toxins, so as to form a conjugate useful in, e.g., in vitro diagnosis, in vivo imaging, and therapy.

Partially loaded antibodies and methods of their conjugation

Growing community of inventors

Bothell, WA, United States of America

Michael Sun